FDA considers effects of managed care marketplace on drug promotional practices.
Wechsler
J
J
D000329:Advertising; D003362:Cost-Benefit Analysis; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004465:Economic Competition; D005569:Formularies as Topic / Q000592:standards*; D008329:Managed Care Programs / Q000191:economics / Q000331:legislation & jurisprudence*; D014481:United States; D014486:United States Food and Drug Administration